IBDEI01G ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,926,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,926,1,3,0)
 ;;=3^Diabetes Type 1 w/ Diabetic Dermatitis
 ;;^UTILITY(U,$J,358.3,926,1,4,0)
 ;;=4^E10.620
 ;;^UTILITY(U,$J,358.3,926,2)
 ;;=^5002615
 ;;^UTILITY(U,$J,358.3,927,0)
 ;;=E10.621^^6^71^14
 ;;^UTILITY(U,$J,358.3,927,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,927,1,3,0)
 ;;=3^Diabetes Type 1 w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,927,1,4,0)
 ;;=4^E10.621
 ;;^UTILITY(U,$J,358.3,927,2)
 ;;=^5002616
 ;;^UTILITY(U,$J,358.3,928,0)
 ;;=E10.622^^6^71^27
 ;;^UTILITY(U,$J,358.3,928,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,928,1,3,0)
 ;;=3^Diabetes Type 1 w/ Other Skin Ulcer
 ;;^UTILITY(U,$J,358.3,928,1,4,0)
 ;;=4^E10.622
 ;;^UTILITY(U,$J,358.3,928,2)
 ;;=^5002617
 ;;^UTILITY(U,$J,358.3,929,0)
 ;;=E10.628^^6^71^26
 ;;^UTILITY(U,$J,358.3,929,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,929,1,3,0)
 ;;=3^Diabetes Type 1 w/ Other Skin Complications
 ;;^UTILITY(U,$J,358.3,929,1,4,0)
 ;;=4^E10.628
 ;;^UTILITY(U,$J,358.3,929,2)
 ;;=^5002618
 ;;^UTILITY(U,$J,358.3,930,0)
 ;;=E10.630^^6^71^29
 ;;^UTILITY(U,$J,358.3,930,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,930,1,3,0)
 ;;=3^Diabetes Type 1 w/ Peridontal Disease
 ;;^UTILITY(U,$J,358.3,930,1,4,0)
 ;;=4^E10.630
 ;;^UTILITY(U,$J,358.3,930,2)
 ;;=^5002619
 ;;^UTILITY(U,$J,358.3,931,0)
 ;;=E10.638^^6^71^20
 ;;^UTILITY(U,$J,358.3,931,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,931,1,3,0)
 ;;=3^Diabetes Type 1 w/ Oral Complications
 ;;^UTILITY(U,$J,358.3,931,1,4,0)
 ;;=4^E10.638
 ;;^UTILITY(U,$J,358.3,931,2)
 ;;=^5002620
 ;;^UTILITY(U,$J,358.3,932,0)
 ;;=E10.69^^6^71^28
 ;;^UTILITY(U,$J,358.3,932,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,932,1,3,0)
 ;;=3^Diabetes Type 1 w/ Other Specified Complication
 ;;^UTILITY(U,$J,358.3,932,1,4,0)
 ;;=4^E10.69
 ;;^UTILITY(U,$J,358.3,932,2)
 ;;=^5002624
 ;;^UTILITY(U,$J,358.3,933,0)
 ;;=E10.8^^6^71^34
 ;;^UTILITY(U,$J,358.3,933,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,933,1,3,0)
 ;;=3^Diabetes Type 1 w/ Unspec Complications
 ;;^UTILITY(U,$J,358.3,933,1,4,0)
 ;;=4^E10.8
 ;;^UTILITY(U,$J,358.3,933,2)
 ;;=^5002625
 ;;^UTILITY(U,$J,358.3,934,0)
 ;;=E11.9^^6^71^70
 ;;^UTILITY(U,$J,358.3,934,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,934,1,3,0)
 ;;=3^Diabetes Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,934,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,934,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,935,0)
 ;;=E11.65^^6^71^48
 ;;^UTILITY(U,$J,358.3,935,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,935,1,3,0)
 ;;=3^Diabetes Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,935,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,935,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,936,0)
 ;;=E11.21^^6^71^42
 ;;^UTILITY(U,$J,358.3,936,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,936,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Nephropathy
 ;;^UTILITY(U,$J,358.3,936,1,4,0)
 ;;=4^E11.21
 ;;^UTILITY(U,$J,358.3,936,2)
 ;;=^5002629
 ;;^UTILITY(U,$J,358.3,937,0)
 ;;=E11.22^^6^71^39
 ;;^UTILITY(U,$J,358.3,937,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,937,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Chr Kidney Disease
 ;;^UTILITY(U,$J,358.3,937,1,4,0)
 ;;=4^E11.22
 ;;^UTILITY(U,$J,358.3,937,2)
 ;;=^5002630
 ;;^UTILITY(U,$J,358.3,938,0)
 ;;=E11.29^^6^71^55
 ;;^UTILITY(U,$J,358.3,938,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,938,1,3,0)
 ;;=3^Diabetes Type 2 w/ Other Diabetic Kidney Complication
 ;;^UTILITY(U,$J,358.3,938,1,4,0)
 ;;=4^E11.29
 ;;^UTILITY(U,$J,358.3,938,2)
 ;;=^5002631
 ;;^UTILITY(U,$J,358.3,939,0)
 ;;=E11.311^^6^71^68
 ;;^UTILITY(U,$J,358.3,939,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,939,1,3,0)
 ;;=3^Diabetes Type 2 w/ Unspec Diabetic Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,939,1,4,0)
 ;;=4^E11.311
 ;;^UTILITY(U,$J,358.3,939,2)
 ;;=^5002632
 ;;^UTILITY(U,$J,358.3,940,0)
 ;;=E11.319^^6^71^69
 ;;^UTILITY(U,$J,358.3,940,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,940,1,3,0)
 ;;=3^Diabetes Type 2 w/ Unspec Diabetic Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,940,1,4,0)
 ;;=4^E11.319
 ;;^UTILITY(U,$J,358.3,940,2)
 ;;=^5002633
 ;;^UTILITY(U,$J,358.3,941,0)
 ;;=E11.321^^6^71^49
 ;;^UTILITY(U,$J,358.3,941,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,941,1,3,0)
 ;;=3^Diabetes Type 2 w/ Mild Nonprlf Diabetic Rtnop w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,941,1,4,0)
 ;;=4^E11.321
 ;;^UTILITY(U,$J,358.3,941,2)
 ;;=^5002634
 ;;^UTILITY(U,$J,358.3,942,0)
 ;;=E11.329^^6^71^50
 ;;^UTILITY(U,$J,358.3,942,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,942,1,3,0)
 ;;=3^Diabetes Type 2 w/ Mild Nonprlf Diabetic Rtnop w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,942,1,4,0)
 ;;=4^E11.329
 ;;^UTILITY(U,$J,358.3,942,2)
 ;;=^5002635
 ;;^UTILITY(U,$J,358.3,943,0)
 ;;=E11.331^^6^71^51
 ;;^UTILITY(U,$J,358.3,943,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,943,1,3,0)
 ;;=3^Diabetes Type 2 w/ Moderate Nonprlf Diabetic Rtnop w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,943,1,4,0)
 ;;=4^E11.331
 ;;^UTILITY(U,$J,358.3,943,2)
 ;;=^5002636
 ;;^UTILITY(U,$J,358.3,944,0)
 ;;=E11.339^^6^71^52
 ;;^UTILITY(U,$J,358.3,944,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,944,1,3,0)
 ;;=3^Diabetes Type 2 w/ Moderate Nonprlf Diabetic Rtnop w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,944,1,4,0)
 ;;=4^E11.339
 ;;^UTILITY(U,$J,358.3,944,2)
 ;;=^5002637
 ;;^UTILITY(U,$J,358.3,945,0)
 ;;=E11.341^^6^71^65
 ;;^UTILITY(U,$J,358.3,945,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,945,1,3,0)
 ;;=3^Diabetes Type 2 w/ Severe Nonprlf Diabetic Rtnop w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,945,1,4,0)
 ;;=4^E11.341
 ;;^UTILITY(U,$J,358.3,945,2)
 ;;=^5002638
 ;;^UTILITY(U,$J,358.3,946,0)
 ;;=E11.349^^6^71^66
 ;;^UTILITY(U,$J,358.3,946,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,946,1,3,0)
 ;;=3^Diabetes Type 2 w/ Severe Nonprlf Diabetic Rtnop w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,946,1,4,0)
 ;;=4^E11.349
 ;;^UTILITY(U,$J,358.3,946,2)
 ;;=^5002639
 ;;^UTILITY(U,$J,358.3,947,0)
 ;;=E11.351^^6^71^63
 ;;^UTILITY(U,$J,358.3,947,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,947,1,3,0)
 ;;=3^Diabetes Type 2 w/ Prolif Diabetic Rtnop w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,947,1,4,0)
 ;;=4^E11.351
 ;;^UTILITY(U,$J,358.3,947,2)
 ;;=^5002640
 ;;^UTILITY(U,$J,358.3,948,0)
 ;;=E11.359^^6^71^64
 ;;^UTILITY(U,$J,358.3,948,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,948,1,3,0)
 ;;=3^Diabetes Type 2 w/ Prolif Diabetic Rtnop w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,948,1,4,0)
 ;;=4^E11.359
 ;;^UTILITY(U,$J,358.3,948,2)
 ;;=^5002641
 ;;^UTILITY(U,$J,358.3,949,0)
 ;;=E11.36^^6^71^38
 ;;^UTILITY(U,$J,358.3,949,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,949,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Cataract
 ;;^UTILITY(U,$J,358.3,949,1,4,0)
 ;;=4^E11.36
 ;;^UTILITY(U,$J,358.3,949,2)
 ;;=^5002642
 ;;^UTILITY(U,$J,358.3,950,0)
 ;;=E11.39^^6^71^57
 ;;^UTILITY(U,$J,358.3,950,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,950,1,3,0)
 ;;=3^Diabetes Type 2 w/ Other Diabetic Ophthalmic Complication
 ;;^UTILITY(U,$J,358.3,950,1,4,0)
 ;;=4^E11.39
 ;;^UTILITY(U,$J,358.3,950,2)
 ;;=^5002643
 ;;^UTILITY(U,$J,358.3,951,0)
 ;;=E11.40^^6^71^44
 ;;^UTILITY(U,$J,358.3,951,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,951,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Neuropathy,Unspec
 ;;^UTILITY(U,$J,358.3,951,1,4,0)
 ;;=4^E11.40
 ;;^UTILITY(U,$J,358.3,951,2)
 ;;=^5002644
 ;;^UTILITY(U,$J,358.3,952,0)
 ;;=E11.49^^6^71^56
 ;;^UTILITY(U,$J,358.3,952,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,952,1,3,0)
 ;;=3^Diabetes Type 2 w/ Other Diabetic Neurological Complication
 ;;^UTILITY(U,$J,358.3,952,1,4,0)
 ;;=4^E11.49
 ;;^UTILITY(U,$J,358.3,952,2)
 ;;=^5002649
 ;;^UTILITY(U,$J,358.3,953,0)
 ;;=E11.41^^6^71^41
 ;;^UTILITY(U,$J,358.3,953,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,953,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Mononeuropathy
